Skip to content
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
Menu
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
Menu
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
Read more about the article Will the magic of psychedelics transform psychiatry?

Will the magic of psychedelics transform psychiatry?

  • Post author:Olly PP
  • Post published:November 7, 2021
  • Post category:Industry News
  • Post comments:0 Comments

Continue ReadingWill the magic of psychedelics transform psychiatry?
Read more about the article Magic Mushrooms and Ecstasy: New Treatment For Autism Spectrum Disorders?

Magic Mushrooms and Ecstasy: New Treatment For Autism Spectrum Disorders?

  • Post author:Olly PP
  • Post published:November 1, 2021
  • Post category:Industry News
  • Post comments:0 Comments

Continue ReadingMagic Mushrooms and Ecstasy: New Treatment For Autism Spectrum Disorders?
Read more about the article Boris Johnson to consider calls to legalise magic mushroom drug psilocybin

Boris Johnson to consider calls to legalise magic mushroom drug psilocybin

  • Post author:Olly PP
  • Post published:October 20, 2021
  • Post category:Industry News
  • Post comments:0 Comments

Continue ReadingBoris Johnson to consider calls to legalise magic mushroom drug psilocybin
Read more about the article Real World Evidence (RWE) Drug Development: A Faster/Cheaper Route For Psychedelics

Real World Evidence (RWE) Drug Development: A Faster/Cheaper Route For Psychedelics

  • Post author:Olly PP
  • Post published:October 19, 2021
  • Post category:Industry News
  • Post comments:0 Comments

Continue ReadingReal World Evidence (RWE) Drug Development: A Faster/Cheaper Route For Psychedelics
Read more about the article Can Psychedelic Drugs Treat Physical Pain?

Can Psychedelic Drugs Treat Physical Pain?

  • Post author:Olly PP
  • Post published:September 30, 2021
  • Post category:Industry News
  • Post comments:0 Comments

Continue ReadingCan Psychedelic Drugs Treat Physical Pain?
Read more about the article Ecstasy, LSD and magic mushrooms: are these drugs the future of therapy?

Ecstasy, LSD and magic mushrooms: are these drugs the future of therapy?

  • Post author:Olly PP
  • Post published:September 13, 2021
  • Post category:Industry News
  • Post comments:0 Comments

Continue ReadingEcstasy, LSD and magic mushrooms: are these drugs the future of therapy?
Read more about the article Psychedelic Drugs Market Global Industry Analysis (2018 – 2020)

Psychedelic Drugs Market Global Industry Analysis (2018 – 2020)

  • Post author:Olly PP
  • Post published:August 30, 2021
  • Post category:Industry News

Continue ReadingPsychedelic Drugs Market Global Industry Analysis (2018 – 2020)
Read more about the article Op-Ed: Psychedelic treatments are here, but doctors aren’t prepared

Op-Ed: Psychedelic treatments are here, but doctors aren’t prepared

  • Post author:Olly PP
  • Post published:August 29, 2021
  • Post category:Industry News
  • Post comments:0 Comments

Continue ReadingOp-Ed: Psychedelic treatments are here, but doctors aren’t prepared
Read more about the article Study finds psilocybin repairs brain cell damage associated with depression

Study finds psilocybin repairs brain cell damage associated with depression

  • Post author:Olly PP
  • Post published:July 21, 2021
  • Post category:Industry News
  • Post comments:0 Comments

Continue ReadingStudy finds psilocybin repairs brain cell damage associated with depression
Read more about the article Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

  • Post author:Olly PP
  • Post published:December 30, 2016
  • Post category:Industry News

Continue ReadingPsilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
  • Go to the previous page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • Go to the next page

Recent Posts

  • Albert Labs Management and Board of Director Announcement
  • Expansion of Drug Discovery and a Promising Pipeline
  • Albert Labs Announces Private Placement
  • Letter of Intent (LOI) for First-In-Human studies with iNGENÅ« CRO
  • Albert Labs Provides Corporate Update

Recent Comments

    Innovative mental health medicines for patients with unmet needs

    • Legal Disclaimer
    • Privacy Policy
    • Modern Slavery Statement
    • Cookie Policy
    • Legal Disclaimer
    • Privacy Policy
    • Modern Slavery Statement
    • Cookie Policy

    © 2023 Albert Labs. All Rights Reserved

    • About
    • Team
    • Clinical Trials
    • KRN-101
    • Investing
    • Press & Updates
    • Contact
    • About
    • Team
    • Clinical Trials
    • KRN-101
    • Investing
    • Press & Updates
    • Contact
    Twitter Linkedin Youtube Envelope
    CSE:ABRT
    FSE: VB50
    CSE:ABRT
    FSE: VB50

    About Albert Labs

    We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

    If you would like support or more information around making an investment, please contact [email protected]

    Twitter Linkedin Youtube Envelope

    Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

    • This field is for validation purposes and should be left unchanged.
    Twitter
    Youtube
    Linkedin
    Instagram
    Envelope
    Twitter
    Youtube
    Linkedin
    Instagram
    Envelope

    By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.